Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Wheels Up Experience Inc. is a provider of on-demand private aviation in the United States. The Company offers a complete global aviation solution with a large and diverse fleet and a global network ...
Copyright 2026 The Denver Post. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms ...
March 29, 2026 • As many as 50 million people in the United States are thought to struggle with an addiction to drugs or alcohol. The majority don’t get treatment for it, and of those who do seek ...
March 31, 2026 • The Department of Homeland Security has lifted its ban on reviewing asylum applications. And, NPR has confirmed that an Iranian strike injured over a dozen U.S. personnel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results